Company Filing History:
Years Active: 2014
Title: The Innovative Journey of Karen Briner in the Field of Pharmaceutical Patents
Introduction
Karen Briner, based in Indianapolis, IN, has made significant strides in the pharmaceutical industry with her innovative contributions. As an inventor with one patent to her name, she showcases a commitment to scientific advancement aimed at addressing mental health and related disorders. Her work primarily focuses on developing selective receptor agonists that can potentially transform treatment options for various conditions.
Latest Patents
Karen Briner holds a patent for her invention concerning 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula (I). This groundbreaking invention offers the potential to serve as selective 5-HT2c receptor agonists for treating disorders linked to the 5-HT2c receptor, including obesity, obsessive-compulsive disorder, depression, and anxiety. The detailed specification outlines that R6 is —NR10R11, with R10 indicating a substituted phenylalkyl or substituted pyridylalkyl structure among other specific substitutions.
Career Highlights
Currently, Karen Briner is employed at Eli Lilly and Company, a leader in the pharmaceutical sector. Her role there highlights her contribution to the development of innovative therapies that target important health challenges. Her distinguished career serves as an exemplary model of how inventors can drive change through their innovations.
Collaborations
Throughout her career, Karen has collaborated with esteemed colleagues, including Manuel Javier Cases-Thomas and Marta Adeva Bartolome. These partnerships foster a collaborative environment that enhances creativity and innovation within the pharmaceutical research community.
Conclusion
The journey of Karen Briner is a testament to the importance of innovation in addressing complex health issues. Her patent work not only reflects her dedication as an inventor but also her contribution to the broader field of pharmaceutical advancements. As she continues her work at Eli Lilly and Company, the potential impact of her inventions on patient care is profound, and her story serves as an inspiration for future inventors in the health sciences.